HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. [electronic resource]
Producer: 20200601Description: 2135-2145 p. digitalISSN:- 1538-8514
- Animals
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- ErbB Receptors -- genetics
- Gene Expression Regulation, Neoplastic
- Humans
- MAP Kinase Signaling System
- Male
- Mice
- Phosphatidylinositol 3-Kinases -- metabolism
- Receptor, ErbB-2 -- genetics
- Stomach Neoplasms -- drug therapy
- TOR Serine-Threonine Kinases -- metabolism
- Trastuzumab
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.